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Recent thymic emigrants can be identified by T cell receptor ex-
cision circles (TRECs) formed during T-cell receptor rearrange-
ment. Decreasing numbers of TRECs have been observed with
aging and in human immunodeficiency virus (HIV)-1 infected
individuals, suggesting for thymic impairment. Here, we show
that in healthy individuals, declining thymic output will affect
the TREC content only when accompanied by naive T-cell divi-
sion. The rapid decline in TRECs observed during HIV-1 infec-
tion and the increase following HAART are better explained not
by thymic impairment, but by changes in peripheral T-cell divi-
sion rates. Our data indicate that TREC content in healthy indi-
viduals is only indirectly related to thymic output, and in HIV-1
infection is mainly affected by immune activation.
It was postulated that HIV-1 induced CD4+ T cell depletion could
at least partially be due to interference of HIV with de novo pro-
duction of T cells at the level of T cell progenitor function or
thymic output. Several studies have focused on the influence of
HIV-1 infection on thymic function, although the results were
inconclusive1,2. Recently, a new method has been reported by
Douek and colleagues3 that may allow a more direct estimation
of thymic T cell production. Formation of a productive T cell re-
ceptor (TCR)α-gene requires deletion of the TCRδ-gene, which is
positioned within the TCRα-locus4. The TCRδ-gene is flanked by
two TCRδ-deleting elements, δRec and ψJ-α, which preferentially
rearrange to each other, thereby deleting the TCRδ locus5–7. The
deleted TCRδ-gene remains present as an extrachromosomal cir-
cular excision product, the so-called signal joint T-cell receptor
excision circle (Sj TREC or TREC) (refs. 8 and 9). These circles are
episomal, do not replicate during mitosis and are thus diluted
during cell division4,8. With quantitative polymerase chain reac-
tion (PCR), TRECs can be detected and quantified, thereby offer-
ing a tool to identify recent thymic emigrants and to estimate
thymic output. Using TREC measurements, it was suggested
that, although thymic function declines with age, limited
thymic output was still measurable at old age3,10–12. In HIV-1 in-
fected individuals, low TREC contents in T cells and PBMC were
reported in a large percentage of patients studied3,10,13. TREC con-
tent increased during highly active anti-retroviral therapy
(HAART), suggestive for improvement of pre-treatment impair-
ment of thymic function3,10. However, the effect of dilution of
these episomal circles, resulting from repeated episodes of
pathogen induced cell division during life, or from a chronically
activated state of the immune system such as observed in HIV-1
infection14–16, has not been taken into account in analyses and
interpretation of these data. Here we combined measurements of
TRECs and cell division rates in naive T cells of healthy and HIV-
1 infected individuals with mathematical modeling, to come to a
better interpretation of TREC measurements with respect to
thymic output.
Sj TRECs in healthy individuals
First, to validate the assay, we measured the TREC content of
CD4+ and CD8+ T cells of 49 HIV-1 negative individuals, from 0
(cord blood) to 84 years of age. The number of TREC copies de-
clined with increasing age (Ps < 0.001, Rs = -0.800, data not
shown). To study whether TRECs were diluted by cell prolifera-
tion, we cultured cord blood peripheral mononuclear cells
(PBMC) from HIV-1 negative donors with interleukin (IL)7 (10
ng/ml) and phytohemagglutinin (PHA, 1 µg/ml) for 7 days.
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Fig. 1 Correlation between TRECs and naive T-cell numbers. In HIV-1
infected Dutch patients () and non-infected individuals (), the num-
ber of TRECs per CD45RA+ CD4+ T cell and the size of this subset are cor-
related (RP = 0.427, PP = 0.003). () represent HIV-negative Ethiopian
individuals (see text).
Sequentially, the number of PBMC, the proportion of cell death
and TRECs were measured. As expected, in vitro cell division led
to dilution of TRECs (data not shown). We recently demon-
strated that during HIV-1 infection peripheral T-cell division
rates are differentially increased in all lymphocyte subsets, in-
cluding the naive CD4+ and naive CD8+ T-cell pools14. This may
confound the interpretation of TREC analysis when measured in
total PBMC or non-separate CD4+ and CD8+ T cells. We have
found that the number of TRECs in the naive CD4+ T-cell pool
(FACS-sorted purified CD27+ CD45RA+ cells) is relatively high, al-
though significant numbers of TRECs were also detected in the
memory population12 (data not shown). Because of practical lim-
itations, TREC analysis could only be performed on purified
CD45RA+ T cells and not on ‘truly naive’ fractions defined by co-
expression of CD27. Therefore, subsequent TREC analysis was
performed exclusively in purified CD45RA+ CD4+ and CD45RA+
CD8+ T-lymphocyte subsets, in parallel with assessment of pe-
ripheral cell division rates in the CD27+ CD45RA+ subsets using
Ki-67 expression17 (see Methods). Throughout the text, the term
‘naive’ denotes truly naive T cells, as being CD45RA+ and CD27+,
otherwise the term CD45RA+ is used.
Sj TRECs during HIV-1 infection
Table 1 shows characteristics of HIV-1 infected patients and age
matched healthy individuals that were in-
cluded in our study. HIV-1 infected patients
had lower numbers of CD4+, and higher
numbers of CD8+ T cells, compared to
healthy individuals. The number of naive
CD4+, but not naive CD8+ T cells, was signifi-
cantly reduced. Percentages of Ki-67+ naive T
cells were increased in these subsets. The
percentage of Ki-67+ naive CD4+ T cells was
negatively correlated with the number of
naive CD4+ T lymphocytes, as reported pre-
viously14 (Rs = - 0.843, Ps < 0.001; data not
shown). HIV-1 infected patients had a signif-
icantly lower TREC content of CD45RA+
CD4+ and CD45RA+ CD8+ T lymphocytes
compared to healthy subjects. The number
of TRECs per CD45RA+ T cell correlated with
the size of the naive CD4+ T-cell pool, such
that patients with high naive T cell numbers
had a high CD45RA+ CD4+ T-cell TREC con-
tent (RP = 0.427, PP = 0.003; Fig. 1).
Effects of thymic output and cell division
The TREC content of a naive T cell population may depend to
various extents on thymic production, cell death and cell divi-
sion, priming of naive T cells to become memory lymphocytes
and intracellular degradation of TRECs (ref. 18). We therefore de-
veloped a mathematical model to interpret our data.
In this model, N is the total number of naive (CD4+ or CD8+) T
cells and T the total amount of TRECs in the naive T-cell popula-
tion, σ(a) is the age (a)-dependent source of naive T cells from
the thymus, α the rate of naive T-cell division, δ the rate of cell
death and priming of naive cells and c is the amount of TRECs in
recent thymic emigrants (RTEs). Changes in the number of naive
T cells can be described as dN/dt = σ(a) + αN - δN (Equation 1).
The total amount of TRECs in this population increases propor-
tionally to thymic production, and decreases when naive T cells
die, become primed or possibly because of intracellular degrada-
tion of the TRECs (δi), and can be expressed as dT/dt = cσ(a) - δT -
δiT (Equation 2).
Note that the total amount of TRECs in the naive T-cell popula-
tion does not decrease by division (α). Division only affects the
average TREC content per naive T cell. By the ‘quotient-rule’ of
differentiation, this average, defined as A = T/N, should change
according to dA/dt = σ(a) (c - A) / N - δi A - αA (Equation 3).
The quasi steady state is at Â = c / [1 + N (δi + α) / σ(a)] (Equation
4). In the absence of division and degradation, when δi + α = 0,
the steady state is Â = c. In other words, lower thymic output is
only reflected by a reduction in TREC content of a naive cell
when there is division of naive T cells (α > 0), and/or intracellular
degradation (δi > 0). Moreover, if the number of naive T cells N in
our model remains proportional to thymic production σ(a), the
σ(a) term cancels from Equation 4. Thus, in that case the TREC
content per naive T cell is essentially a measure of division
and/or degradation, not of thymic output.
To validate our model, we studied quantitatively how the dif-
ferent parameters are expected to influence the average TREC
content of a naive T cell. In the following equation thymus pro-
duction is assumed to decay exponentially and division to be
density dependent: σ(a) = σ0 exp [- va] (Equation 5a), and α = α0 /
(1 + N2 / h2) (Equation 5b), where σ0 is the newborn thymus pro-
duction of naive T cells, v the involution rate of the thymus, σ0
Table 1 Characteristics of healthy individuals and HIV-1 infected patients
CD4+ T cells CD8+ T cells
HIV– HIV+ P HIV– HIV+ P
(n = 17) (n = 33) (n = 14) (n = 7)
Age 37 41 ns 40 42 ns
(years) (24–62) (24–57) (24–62) (27–54)
T cells 880 400 < 0.001 405 1570 < 0.001
(per µl) (620–1430) (160–1350) (210–640) (770–2720)
Naive T cells 494 150 < 0.001 248 218 ns
(per µl) (276–1027) (22–756) (149–354) (126–440)
Ki-67+ naive T cells 0.4 3.1 < 0.001 0.3 3.4 < 0.001
(%) (0.1–0.8) (0.7–5.7) (0.1–0.9) (1.7–30.7)
Sj TRECs(×10-3 copies 25.1 12.1 < 0.05 31.4 2.5 < 0.001
/CD45RA+ cell) (5.5–221.4) (0.08–57.1) (4.2–219.1) (0.13–7.8)
Depicted are median and range. Statistical significance was calculated with the Mann-Whitney U test; P < 0.05 was
considered statistically significant.
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is the maximum division rate of naive T cells (which is ap-
proached at the lowest naive T-cell counts) and h the naive T-
cell count at which the division is half maximal. This model is
in good agreement with the data obtained from healthy indi-
viduals12 (Fig.2). In all three panels, the thymic output de-
creases exponentially, but the naive T-cell population is
maintained by only modest homeostatic changes in either the
division (α) or the death (δ) rate (see equation 5c). In the case
of a density dependent increase in division rate (α), the average
number of TRECs per naive T cell remains high until puberty,
and then decreases several orders of magnitude (Fig. 2a).
Alternatively, the lifespan of naive T lymphocytes could be
prolonged with the decrease in T-cell density that is associated
with age-related decline in thymic output. Therefore, we in-
cluded density dependent death of naive T cells, described as δ
= δ0 + εN (Equation 5c) in our model. In this equation, εN allows
for a density dependent increase in death rate. The average TREC
content also declines orders of magnitude when there is a density
dependent decrease in the death rate (ε > 0) and a constant naive
T-cell division rate (α = α0, Fig. 2b).
However, when α = 0 and δ is density
dependent, the average TREC content
remains constant during life (Fig. 2c).
When TRECs are measured in sepa-
rated CD45RA+ T cell populations,
rather then in ‘truly naive’ T cells, re-
version of CD45RA- memory cells into
this population could also affect the
TREC content. Reversion can be in-
cluded in our model by allowing for a
‘source’ of revertants, R, in Equation 1.
Because revertant memory cells should
contain little or no TRECs, Equation 2
should remain the same. The R term re-
flects the number of memory cells re-
verting to a naive phenotype on a daily
basis. We have studied the extended
model numerically and found that re-
version can only have an observable ef-
fect on the TREC content when more
than half of the total production of naive T cells is due to rever-
sion (i.e., when R > σ(a) + αN). Although there might be rever-
sion of some memory cells19–21, it seems unlikely that this occurs
at such high rate in healthy people20. Thus, in our model it is the
increase in division rate around puberty that sets the decrease in
TREC content after puberty. Furthermore, CD45RA- CD45RO+
memory cells are thought to revert to a CD45RA+ CD45RO- phe-
notype only when in a resting state, that is, in the absence of
their specific antigen. In HIV-1 infection, given the hyperactiva-
tion, this is probably a rare event. If a substantial reversion rate
does exist, it just enhances the decreasing effect of naive T-cell
division on TREC content. In any case, peripheral cell division is
required (assuming no intracellular decay), and is an important
factor, for decreasing TREC content.
Effects of HIV-1 infection on TREC content
HIV-1 infection could influence the TREC content of the naive T
cell compartment in various ways: 1) direct infection of the thy-
mus could lead to abolishment of thymic production (σ), 2) HIV-
mediated killing of naive cells or an increase in the rate of
priming into memory cells could lead to an increasing loss of
naive T cells (δ), or 3) direct activation of naive T cells, or virus-
induced depletion of the naive T-cell compartment, inducing a
homeostatic response, could lead to a rise in naive T-cell division
rates (α).
We investigated these effects separately, by choosing a 30-year
old individual from Fig. 2 and studying the impact of the above
mentioned possibilities during one year of HIV-1 infection (Fig.
3). Blocking thymus production (σ = 0) hardly influenced the av-
erage TREC content or naive T cell numbers (Fig. 3a). This is ex-
plained by the longevity of these cells. Increasing the death and
priming rate δ 10-fold led to a decrease in the number of naive T
cells and an increase in the TREC content of naive T cells (Fig.
3b). The latter is due to the fact that by increasing the death rate,
the average naive T cell will become younger. Thus, a larger frac-
tion of all naive T cells will be a recent thymic emigrant, and will
hence have a higher average TREC content. Finally, increasing
the division rate α 10-fold had a strong and rapid effect on the
TRECs (Fig. 3c). Various values of α were tested, and even when
naive T-cell division was increased only threefold compared to
normal rates, the TREC content of the naive T-cell population
a b c
Table 2 Characteristics of HIV-1 negative Ethiopian individuals
Ethiopians Comparison to:
(n = 18) HIV- HIV+
Age 42 ns ns
(years) (35-45)
CD4 T cells 748 ns P < 0.001
(per µl) (427-1354)
Naive CD4 112 P < 0.001 ns
(per µl) (36-316)
Ki67+ naive 0.9 P < 0.05 P < 0.005
CD4 (%) (0.2-6.2)
Sj TRECs 4.9 P < 0.001 P < 0.01
(×10−3 copies/
CD45RA+ cell)
Depicted are median and range. Values were compared to the Dutch HIV-negative
(HIV-; n = 17) and HIV-1 infected (HIV+; n = 33) subjects described in Table 1.
Statistical significance was calculated with the Mann-Whitney U test; P < 0.05 was
considered statistically significant.
Fig. 2 The model behavior as a function of age (a, b and c). Thymic output declines exponentially, and
the naive T cell population is maintained by (a) a modest increase in cell division (α), (b) a density de-
pendent decrease in death rate (δ) and a constant cell division rate (α = 10–3), or (c) a density dependent
decrease in death rate (δ) in the absence of cell division (α0=0). Solid lines represent TREC content per
naive T cell, dashed lines the total number of naive T cells. a, α0 = 0.1/day, δ = 10-3/day and ε = 0. b, α =
10-3, δ0 = 0/day and ε = 9.1 × 10-16. c, α0 = δ = 0/day, and ε = 8.9 × 10-16. Parameters: c = 1, δi = 0, h = 2.5
× 1010 cells, σ0 = 109 cells/day and v = 0.1/year.
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did reduce (data not shown). To simulate HIV-1 infection more
realistically, we simultaneously increased the cell division rate α
and death and priming rate δ 5-fold. This led to the observed loss
of TRECs and a slow decrease in naive T cell numbers (data not
shown). Theoretically, increasing the intracellular degradation
rate δi 10-fold could lead to a similar decrease in TRECs, however,
the normal lifespan of a TREC is not known, and it seems un-
likely that HIV-1 infection could affect TRECs in this manner.
Thus, our model shows that the decrease in TRECs during
the relatively short period of HIV-1 infection (3–7 years) is
most simply explained by increased division rates in the naive
T-cell compartment. We have recently shown that this is
mostly driven by immune activation rather than by homeo-
static mechanisms14. This explanation is supported by our ob-
servation that the proportion of Ki-67+ naive T cells was
negatively correlated with the number of TRECs per CD45RA+
T cell (Rs = -0.556, Ps = 0.001 and RP = -0.74, PP = 0.001 for CD4+
and CD8+ T cell subsets respectively, Fig. 4a and b).
Furthermore, compared with the group of healthy individuals,
HIV-infected patients had a significantly decreased TREC con-
tent of the CD45RA+ CD8+ T-cell pool, but did not have lower
numbers of naive CD8+ T cells (Table 1). This is in agreement
with our previous results, demonstrating that
cell division rates in the naive CD8+ T cell com-
partment were increased in patients with nor-
mal numbers of naive CD8+ T cells14. Finally,
although naive T cell division is the simplest
explanation, it does not exclude the possibility
that reversion of memory cells from the
CD45RA- to the CD45RA+ phenotype con-
tributes to the observed decrease in TREC con-
tent, especially for the CD8+ T cells.
Dilution of TRECs by immune activation
To determine whether a decline in TRECs could
be observed independently of HIV-1 infection,
we studied HIV-negative Ethiopians who have a
chronically activated immune system, probably
due to the increased pathogen exposure in the
domestic Ethiopian environment22. Compared to
HIV-negative Dutch individuals, Ethiopians have
lower numbers of naive CD4+ and naive CD8+ T cells, concomi-
tant with an expansion of the primed CD45RO+ CD27– T-cell
compartment22. If the decline in TREC content of the CD45RA+
T-cell population in HIV-1 infection were indeed related to pe-
ripheral dilution caused by cell division, one would expect low
TREC contents in T cells from this group of Ethiopian individu-
als. Eighteen HIV-negative Ethiopians, participating in a cohort
study performed in Akaki, Ethiopia, as part of the
Ethiopian–Netherlands AIDS Research Project (ENARP), were se-
lected based on their seronegative status. Compared with HIV-
negative Dutch subjects, Ethiopian individuals had reduced
numbers of naive CD4+ T cells, increased Ki-67+ naive CD4+ T
cells and decreased CD45RA+ T cell TREC contents (Table 2). The
number of TRECs per CD45RA+ CD4+ T cell in these subjects was
even lower than in the HIV-1 infected Dutch patients included
in our study (Fig. 4c). Even though Ki-67 expression is a measure
for ongoing cell division and not for the replicative history of the
naive cells, it does correlate with low TREC content in these indi-
viduals (Fig. 4a).
Effect of highly active anti-retroviral therapy on TRECs
In the above described group of HIV-1 infected Dutch individu-
als, 1–2 years of HAART led to a rise in peripheral naive T-cell
numbers, a steep reduction in the proportion of dividing cells in
all subsets and a small increase in the TREC content (Fig. 5; data
not shown for CD8+ T cells). None of these parameters reached
normal concentrations (P < 0.01 for all time points, all parame-
ters, compared with healthy subjects). In eight patients, we ana-
lyzed recovery of TRECs shortly after introduction of HAART in
more detail. Immediate increase of TREC content in the
CD45RA+ T cell pool was only observed during the first 3 months
of HAART and coincided with a decline in naive CD4+ T-cell divi-
Fig. 3 The model behavior of an HIV-1 infected, 30-year old individual
over a time period of one year. a, Blocking thymic output, that is, setting σ
= 0, hardly influences the average TREC content (solid line) or naive T-cell
numbers (dashed line). b, Increasing the death and priming rate (δ) 10-
fold, leads to an increase in TREC content and a decrease in the number of
naive T cells. c, Elevating the division rate (α) 10-fold, leads to a decrease in
TREC content and an increase in naive T-cell numbers. d, Increasing both δ
and α 5-fold leads to the observed decrease in the TREC content and in
naive T cell numbers. Parameters: α = 7.9 × 10–4/day, c = 1, δ = 10–3/day, δi
= 0/day and σ = 5 × 107cells/day.
Fig. 4 In vivo dilution of TRECs. (a and b) In HIV-1 infected Dutch patients (), and in non-
infected Dutch individuals () the number of TRECs declines with increasing percentages of
(a) dividing naive CD4+ T cells (Rs = -0.556, Ps = 0.001) and (b) dividing naive CD8+ T cells (RP
= -0.740, PP = 0.001). () represent HIV-negative Ethiopian individuals (see text). c, HIV-nega-
tive Ethiopian individuals have an even lower TREC content per CD45RA+ CD4+ T cell com-
pared with HIV-negative and HIV-infected Dutch subjects (* P < 0.05).
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sion rates, but not with improvement of naive CD4+ T-cell num-
bers. Analysis of the naive CD8+ T cell pool revealed similar dy-
namics (data not shown).
Discussion
Elevated cell division rates could obscure the interpretation of
TREC data. Because many CD45RA- ‘memory’ T cells, particu-
larly, may have a history of very rapid cell division in individuals
with chronically activated immune systems16, lowering the aver-
age TREC content12, we measured Sj TRECs in purified
CD45RA+CD4+ and CD45RA+CD8+ T-cell subsets in parallel with
peripheral cell division rates in the naive populations. We com-
pared data obtained from healthy individuals with those from
subjects that were shown to have a persistently activated im-
mune system, including HIV-1 infected patients14,16 and a group
of HIV-negative Ethiopian factory workers.
Mathematical modeling was used to describe the relation
among the various parameters that affect TREC content. This
showed that when in healthy individuals the net thymic output
decreases, for example because of age-related involution of
thymic tissue, the number of TRECs per produced naive T cell
does not significantly decrease (see equation 3), as has been ex-
perimentally shown11. The mere fact that the TREC content of
naive T cells declines with age12, according to our model suggests
increased naive peripheral T-cell division that accompanies
lower thymic T-cell production.
It is now well established that HIV-1 infection leads to chronic
immune activation reflected in elevated division rates in all T-
cell subsets, including even the naive CD4+ and CD8+ T-cell com-
partment14,16,23. This immune activation is observed immediately
following HIV-1 infection, and is most pronounced in CD8+ T
cells24,25. We measured cell division in truly naive T cells that
were characterized by expression of CD45RA and CD27 antigens.
Contamination of this population by memory cells that reverted
to a naive phenotype is thereby excluded, because expression of
the CD27 antigen is lost upon prolonged antigen-specific stimu-
lation and this loss is irreversible26. Naive T cells can be activated
by stimulatory cytokines, independent of antigen, without los-
ing their naive phenotype27–29. According to the model, naive T
cell division would have a rapid and strong effect on the average
TREC content. Even a two- to threefold increase in cell division
rates, which is not reflected by changes in telomere lengths30,31,
can induce an observable dilution of TRECs. Indeed, TREC con-
tent is low in HIV-1 infection and acute HIV-1 infection leads to
a significant reduction in the number of TRECs already after 90
days10, an observation that our model cannot explain by an im-
mediate fall in thymic output (Fig. 3a). It has been estimated
that in adults, thymic output is in the order of 107 to 108 lym-
phocytes per day32. Even if HIV-1 infection would immediately
and completely abolish thymic output, this alone could not lead
to such a rapid fall in cellular TREC content (Fig. 3a). Elevated
rates of T-cell division of naive cells are the most probable cause
of the reduced TREC content we observed. Our hypothesis is fur-
ther supported by the finding that non-HIV mediated persistent
immune activation in healthy Ethiopians also leads to a signifi-
cant loss of TRECs. However, because mixing with low-TREC re-
vertant memory cells could also contribute to the observed
reduction in TREC content, it will be important to obtain infor-
mation on TREC contents of sorted naive T cells. Indeed, prelim-
inary data from our lab obtained in a small group of HIV-1
infected patients showed lower TREC content of sorted ‘truly
naive’ CD27+CD45RA+CD4+ T cells compared with healthy age-
matched individuals (n = 5 and n = 3, medians 1.3 × 10-3 and 7.2 ×
10-3 Sj TREC copies per CD27+CD45RA+CD4+ T cell, respectively).
Anti-retroviral treatment resulted in improvement of the
TREC content of CD45RA+ T cells, which correlated with declin-
ing naive T-cell division rates, but not with increasing naive T-
lymphocyte numbers. This is in agreement with recent findings
of Zhang et al.10, who found significant HAART- induced recov-
ery of TREC content only in patients with low pre-treatment
numbers of TRECs, which did not correlate with recovery of the
naive T-cell pool. Rather, the increase in TREC content during
HAART most probably is a composite of normalizing naive T cell
peripheral death and division rates14, some redistribution of
naive T cells to the blood33 and a continuous but low, possibly
normal, thymic lymphocyte production.
Taken together, loss of TRECs in HIV-1 infection may primar-
ily be caused by continuous hyperactivation of the immune sys-
tem as reflected by increased cell division even of naive T cells.
Although interference by HIV with thymic output could con-
tribute to CD4+ T-cell depletion3,30,32,34, measurements of TREC
content in CD45RA+ T cells fail to provide experimental evidence
for such thymic impairment. Alternatively, it may be that the in-
trinsically low thymic output in adults cannot compensate for
the continuous loss of naive cells incurred by the increased prim-
ing of naive cells due to persistent immune activation, resulting
in gradual depletion of CD4+ T cells without in fact exhaustion
of thymic output35.
Methods
Subjects. Cryopreserved peripheral blood samples from 33 HIV-1 infected
patients and 35 non-infected healthy subjects were analyzed.
Cryopreservation was performed using a computerized freezing device that
results in optimal quality of frozen cells for functional studies36. Frozen
blood samples were stored in liquid nitrogen. Patient blood samples were
obtained from HIV-1 infected individuals participating in three separate tri-
als: the Amsterdam cohort study on HIV-1 infection in homosexual men (n
= 7), the Bristol Meyers Squibb-50 trial (n = 18) and the CHEESE study (n =
8). Samples were obtained before and during treatment with triple-therapy
regimens, containing two reverse transcriptase inhibitors (nucleoside ana-
logues) and one protease inhibitor. As controls, HIV-1 negative Dutch labo-
ratory personnel (n = 17) and Ethiopian factory workers (n = 18) were
included. HIV-1 negative individuals were age-matched with the HIV-1 in-
fected patients. In 14 out of 17 healthy Dutch individuals, and 7 out of 33
Fig. 5 Effect of HAART on TREC content. The number of naive CD4+ T cells
(), the percentage of Ki-67+ naive CD4+ T cells () and the TREC content
per CD45RA+ CD4+ T cell () were measured in 33 HIV-1 infected individu-
als during untreated HIV-1 infection, after 6 months of HAART and after 1 to
2 years of HAART. At all timepoints, the number of naive cells, Ki-67 expres-
sion in these cells and the number of TRECs were significantly different from
control values (Mann Whitney U test, P < 0.01).
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HIV-infected subjects, enough material was available to perform measure-
ments of TRECs in both the CD45RA+ CD4+ and CD45RA+ CD8+ T-cell
compartment. Selection of HIV-negative Ethiopian factory workers was
based on their numbers of peripheral blood CD4+ T lymphocytes, varying
from fewer than 500 to more than 1000 cells per microliter. No correlation
was found between the TREC content of CD45RA+ CD4+ T cells and the
total number of CD4+ T cells in that population. It is of note that although
total CD4+ T cell numbers varied in this study population, the number of
naive CD4+ T cells was significantly lower compared with HIV-negative
Dutch individuals, even when total CD4+ T cell numbers were comparable
(Table 2).
Cell proliferation. Peripheral blood T-cell proliferation was studied by flow
cytometric measurements of Ki-67 nuclear antigen expression on naive
CD27+ CD45RO- CD4+ and naive CD27+ CD45RO- CD8+ T cells, as described
previously14,37,38. Measurements of cell division rates with this method yield
similar results as have been obtained previously by in vivo labeling of divid-
ing cells with deuterated glucose39. Peripheral blood mononuclear cells
were thawed and incubated with CD4- or CD8-PerCP mAb, CD45RO-PE
(Becton Dickinson, San Jose, California) and biotinylated CD27 mAb (CLB,
Amsterdam, The Netherlands). After washing, cells were incubated with
streptavidin-APC (Becton Dickinson). Cells were then fixated and permeabi-
lized with FACS lysing solution and FACS permeabilization buffer (Becton
Dickinson), respectively. Lymphocytes were stained intracellularly with Ki-
67-FITC mAb (Immunotech, Marseille, France), after which cells were fixed
using Cellfix (Becton Dickinson) and analyzed on a FACSCalibur (Becton
Dickinson) with Cellquest software.
Cell separation. CD45RA+ CD4+ and CD45RA+ CD8+ T cells were purified
from thawed PBMC by magnetic separation over columns, using the
MiniMACS multisort kit according to manufacturer’s instructions (Miltenyi
Biotec Inc, Sunnyvale, California). Briefly, after 15 min incubation with 20 µl
CD4 or CD8 conjugated magnetic beads per 107 cells, CD4+ and CD8+ T
cells were isolated from PBMC by positive selection over MiniMACS separa-
tion columns. Magnetic beads were then released, cells were incubated
with CD45RA-conjugated magnetic beads and passed over columns. With
this technique, at least 90% purity of the fractions was achieved, such that
fewer then 10% of CD4+ or CD8+ T-cell fractions were contaminated with
CD8+ or CD4+ T cells, respectively, or with CD45RA- T cells. As outlined
above, truly naive T cells are defined by co-expression of CD45RA and
CD27, however, due to practical reasons, TREC analysis was performed in
purified CD45RA+ T cells. Contamination of purified CD45RA+ T cells with
CD27- CD45RA+ cells such that it will affect TREC contents cannot be ex-
cluded, especially in the CD8+ T-cell subset of HIV infected individuals26. It
is less likely to occur in CD4+ T cells, because the population of CD4+ CD27-
CD45RA+ T cells is limited in size22.
Real-time PCR. DNA was purified from CD45RA+ CD4+ and CD45RA+ CD8+
T cell fractions using the QIAamp Blood Kit according to manufacturer’s in-
structions (Qiagen, Hilden, Germany) . To detect Sj TRECs, a real-time
quantitative PCR method was used40. In this PCR, annealing of primers with
a site-specific probe, containing a quencher and a reporter dye, results in
AmpliTaq Gold DNA Polymerase mediated cleavage of the probe and sub-
sequent separation of the quencher from the reporter, thereby inducing flu-
orescence of the reporter dye. Each PCR reaction was performed in a 50-µl
solution containing 100–200 ng DNA of cell suspension of interest, 1.0 ×
TaqMan Buffer A (Perkin Elmer Biosystems, Nieuwerkerk a/d IJssel, The
Netherlands), 5.0 mM MgCl2, 200 µM dNTPs, 900 nM forward and reverse
primer, 200 nM probe, and 1.25 U AmpliTaq Gold (PE Biosystems). The se-
quences of the primers and probe used are the following: forward primer
5′–CCATGCTGACACCTCTGGTT–3′, reverse primer 5′–TCGTGAGAACGGT-
GAATGAAG–3′ and the probe 5′–CACGGTGATGCATAGGCACCTGC–3′. As
an internal control measurement, to normalize for input DNA, the Cα con-
stant region that remains present on TCR genes despite rearrangement
processes was amplified in every sample tested (forward primer 5′–CCT-
GATCCTCTTGTCCCACAG–3′; reverse primer 5′–GGATTTAGAGTCTCTCA
GCTGGTACA–3′ and probe 5′–ATCCAGAACCCTGACCCTGCCG–3′). Using
these primer/probe combinations (PE Biosystems), sequences of 131 bp
and 70 bp, respectively, were amplified. A standard was created, by cloning
the Sj fragment in the Hind III site of a pUC-19 vector, and the number of Sj
copies present in a given cell population was calculated by including a dilu-
tion series of this standard in each PCR experiment. PCR was performed
under the following conditions: 50 °C for 2 min followed by 95 °C for 10
min, after which 50 cycles of amplification were carried out (95 °C for 15
sec, 60 °C for 1 min). For each sample the Ct-value, defined as the minimal
number of cycles necessary to exceed threshold values, was measured and
applied to the standardization curve created from the dilution series de-
scribed above.
Statistical analysis. Group characteristics were compared with the Mann-
Whitney U test. Normality of groups was tested using the Shapiro-Wilk W
Test for normality. Based on the outcome of this test, correlations were cal-
culated using either Spearman’s rank correlation coefficient (Rs) or Pearson’s
correlation coefficient (Rp).
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